Selection and characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells (Q57594330)

1

0 references

D Chen

3

0 references

H Chen

4

0 references

S Koido

5

0 references

S J Gendler

6

0 references

I F McKenzie

7

0 references

D Kufe

Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium

8

0 references

language of work or name

English

0 references

publication date

November 2000

0 references

published in

Immunology

0 references

volume

101

0 references

issue

3

0 references

page(s)

316-24

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

MUC1 peptide epitopes associated with five different H-2 class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

A fail-safe mechanism for maintaining self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Capture and processing of exogenous antigens for presentation on MHC molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Human B-cell immune response to the polymorphic epithelial mucin.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Generation, translocation, and presentation of MHC class I-restricted peptides

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Suppression of cellular aggregation by high levels of episialin

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327099

The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM

2 November 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

CD40 ligand-transduced co-stimulation of T cells in the development of helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00101.X

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen

21 January 2018

1 reference

12 December 2020

Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development

1 reference

12 December 2020

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors

1 reference

12 December 2020

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

12 December 2020

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

12 December 2020

Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas

1 reference

12 December 2020

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells

1 reference

12 December 2020

Expression of the gene coding for a human mucin in mouse mammary tumor cells can affect their tumorigenicity

1 reference

12 December 2020

Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides

1 reference

12 December 2020

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients

1 reference

12 December 2020

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

1 reference

12 December 2020

CTL in mice immunized with human mucin 1 are MHC-restricted

1 reference

12 December 2020

Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice

1 reference

12 December 2020

In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors

1 reference

12 December 2020

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

12 December 2020

Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model

1 reference

12 December 2020

Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP)

1 reference

12 December 2020